Equities

Heart Test Laboratories Inc

HSCS:NAQ

Heart Test Laboratories Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)4.09
  • Today's Change0.03 / 0.74%
  • Shares traded12.69k
  • 1 Year change-89.63%
  • Beta--
Data delayed at least 15 minutes, as of Oct 09 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Heart Test Laboratories, Inc., doing business as, HeartSciences is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of AI-ECG algorithms and intends to provide these AI-ECG algorithms on a device agnostic cloud-based solution as well as an ECG hardware platform. The Company applies AI-machine learning to the signal processed ECG signal to develop an algorithm designed to detect impaired cardiac relaxation, or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction. The Company's product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test.

  • Revenue in USD (TTM)18.60k
  • Net income in USD-7.29m
  • Incorporated2007
  • Employees15.00
  • Location
    Heart Test Laboratories Inc550 Reserve St, Suite 360SOUTHLAKE 76092United StatesUSA
  • Phone+1 (682) 237-7781
  • Websitehttps://heartsciences.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Acutus Medical Inc12.16m-5.82m3.16m233.00------0.2596-0.19650.69660.413-0.16390.17911.321.4452,184.55-8.58-46.76-11.07-56.88-13.40-89.12-47.89-773.491.88-3.391.18--136.3627.03-141.35---35.99--
Venus Concept Inc69.81m-49.93m3.19m304.00--0.8623--0.0457-8.38-8.3811.920.51030.7511.032.25229,634.90-53.53-32.71-82.19-44.0168.3968.16-71.28-48.501.30-2.750.9133---23.2628.3114.76---35.08--
Fuse Medical Inc18.40m3.63m3.33m31.001.25--0.90160.18070.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Heart Test Laboratories Inc18.60k-7.29m3.71m15.00--0.6202--199.36-5.65-5.650.00116.550.00350.0092--1,240.00-135.14---193.38--67.31---39,193.76--4.02-20.720.0777--261.17---3.95------
Applied DNA Sciences Inc3.40m-7.52m3.80m53.00--0.3066--1.12-11.86-11.862.181.200.20926.835.6864,114.15-45.51-88.57-55.20-121.9125.0444.35-217.48-113.263.76--0.00---26.4327.92-18.73--33.80--
AccuStem Sciences Inc0.00-1.65m3.97m3.00---------0.1454-0.14540.00-0.25420.00----0.00-551.46--------------------------45.26------
Sonendo Inc37.46m-47.49m3.98m216.00--0.2226--0.1062-0.5017-0.44360.39520.24530.4981.956.91173,421.30-63.14---78.26--35.04---126.79--1.73-8.540.5194--5.30---6.78------
Telesis Bio Inc16.28m-50.12m3.98m137.00------0.2445-29.66-30.689.615.610.19473.153.40118,832.10-57.15---64.21--49.47---293.54--1.72-52.960.356--0.2697---1.14------
Optimus Healthcare Services Inc1.89m-7.16m4.03m12.00------2.13-0.1744-0.17440.0454-0.18891.26--3.67157,291.70-477.28------85.93---379.51-----5.42----22.88---3.51------
BioSig Technologies Inc40.00k-18.08m4.12m4.00------103.08-1.97-1.970.00410.00660.0112--1.0710,000.00-489.14-269.73-4,711.71-363.1165.00---43,760.00-24,485.73---3,115.670.00---93.71---6.52---9.58--
Predictive Oncology Inc1.75m-14.04m4.30m34.00--0.8997--2.46-3.36-3.360.41580.71710.11081.454.2851,425.29-88.98-91.80-121.17-126.2960.2364.64-802.93-1,419.991.37--0.0634--18.244.7545.67--5.44--
Caduceus Software Systems Corp0.00-117.60k4.35m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
Sharps Technology Inc0.00-8.21m4.38m3.00--0.6069-----0.4944-0.49440.000.25240.00-------75.56---100.97----------0.6446--0.00-------112.12------
Kelyniam Global Inc517.70k-420.28k4.39m0.00--8.11--8.48-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Encision Inc6.56m-529.29k4.63m22.00--2.49--0.7056-0.045-0.0450.5560.15661.702.107.59298,337.30-13.69-3.03-19.50-4.1349.0051.25-8.06-1.891.01-8.890.1761---10.38-5.64-113.55---9.54--
Hawkeye Systems Inc0.00-578.72k4.79m44.00---------0.093-0.0930.00-0.30060.00-------117.01-314.04-----------195.39---1.49--------52.81------
Data as of Oct 09 2024. Currency figures normalised to Heart Test Laboratories Inc's reporting currency: US Dollar USD

Institutional shareholders

1.63%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20241.92k0.29%
Tradition Wealth Management LLCas of 31 Mar 20241.81k0.28%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 20241.65k0.25%
Citadel Securities LLCas of 31 Mar 20241.23k0.19%
HRT Financial LLCas of 31 Mar 20241.23k0.19%
Oliver LaGore VanValin Investment Group, Inc.as of 31 Mar 2024704.000.11%
Tower Research Capital LLCas of 31 Mar 2024625.000.10%
Two Sigma Securities LLCas of 31 Mar 2024505.000.08%
Cantor Fitzgerald Europeas of 31 Mar 2024500.000.08%
Cultivar Capital, Inc.as of 30 Jun 2024500.000.08%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.